TheEdgeResearch
Home / Stocks / NVOS

Novo Integrated Sciences, Inc. (NVOS)

OTC Healthcare Medical - Care Facilities
$0.00 ▲ +0.00%
Market Cap
$69,056
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
5.92
52-Wk Range
0.0001-0.06
CEO
Robert Mattacchione
Country
US
Currency
USD

Novo Integrated Sciences, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bellevue, WA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $69,056. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -121.3%. Its beta of 5.92 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.01
Price / Book
0.00
EV / EBITDA
-0.39
Gross margin
43.2%
Operating margin
-62.5%
Net margin
-121.3%
Return on equity
Debt / equity
0.32
Current ratio
0.37
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
115
IPO date
2021-02-23
Headquarters
Bellevue, WA, US
About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Comparable companies

Novo Integrated Sciences, Inc. is most often compared with the following Healthcare names:

ACGIADVTBBBTBRAXFEHOSJNHMFOMHEPBLASETOSONX
More research on NVOS
NVOS technical analysis NVOS TheEdge Score Compare against peers
Open full interactive analysis & DCF →